This inventor holds 2 USPTO granted patents. Top assignees: Nippon Oil Company, Teijin Limited. Active years: 1995-1996.
Company Filing History:
Years Active: 1995-1996
Title: Tetsuo Toraya: Innovator in Vitamin B.sub.12 Derivatives
Introduction
Tetsuo Toraya is a notable inventor based in Okayama, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of novel vitamin B.sub.12 derivatives. With a total of 2 patents, his work has implications for both pharmaceutical applications and biological research.
Latest Patents
One of Toraya's latest patents focuses on hydrophobic vitamin B.sub.12 derivatives. This innovative derivative is represented by a specific formula wherein R denotes an alkyl group with 2 to 17 carbon atoms, and X can be a cyano group, hydroxyl group, alkyl group, or a 5'-deoxyadenosyl group. The hydrophobic nature of this derivative allows for its uptake by organisms through thermodynamic diffusion, eliminating the need for active transport. Another significant patent involves vitamin B.sub.12 compounds, salts, and pharmaceutical compositions. These compounds are represented by a formula where L is a ligand to the cobalt of the corrin ring, selected from cyano or adenosyl groups, while B is an imidazole group or a 5,6-dimethylbenzimidazole group. The preparation methods and applications of these compounds in various biological studies are also disclosed.
Career Highlights
Throughout his career, Tetsuo Toraya has worked with prominent companies such as Teijin Limited and Nippon Oil Company. His experience in these organizations has contributed to his expertise in the field of biochemistry and innovation.
Collaborations
Toraya has collaborated with notable individuals in his field, including Atsuhiko Ishida and Yasuhide Uejima. These collaborations have likely enriched his research and development efforts.
Conclusion
Tetsuo Toraya's contributions to the field of vitamin B.sub.12 derivatives highlight his innovative spirit and dedication to advancing biochemistry. His patents reflect a commitment to improving pharmaceutical applications and understanding biological processes.
